サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1505174

蛍光誘導手術システムの世界市場：2024年～2031年

Global Fluorescence Guided Surgery System Market 2024-2031

出版日
ページ情報
英文 140 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
蛍光誘導手術システムの世界市場：2024年～2031年
出版日: 2024年06月23日
発行: Orion Market Research
ページ情報: 英文 140 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

蛍光誘導手術システム市場は予測期間（2024-2031年）にCAGR 15.7％で成長すると予測されます。蛍光誘導手術（FGS）は、手術中に不可視光を使って手術部位のリアルタイム画像を作成する光学イメージング技術です。これにより、外科医は腫瘍、がん細胞、神経などの解剖学的特徴をより正確かつ高精度に特定し、除去または温存することができます。FGSはまた、健康な組織を損傷するリスクを減らすことができるため、手術時間を短縮し、再手術の必要性を減らすことができます。

市場力学

手術件数の増加

外科手術の件数、ヘルスケア支出、規制当局の承認はすべて増加すると予想され、これが世界のFGSシステム市場の成長を促進します。悪性細胞や標的組織に極めて選択的な改良型蛍光プローブは研究開発の成果です。手術中、これらのプローブは医師が手術部位をより鮮明に見るのに役立ちます。FGSが患者の予後を改善することが臨床的に証明されているため、医療施設は手術中にFGSを導入する意欲を高めています。

増加する研究開発数

研究開発活動の結果、悪性細胞やその他の標的組織に極めて選択的な、より高度な蛍光プローブが生み出されています。これらのプローブを使用することで、医師は手術部位をより鮮明に見ながら手術を行うことができます。拡大する臨床データコレクションは、FGSが患者の転帰を改善したことを示しています。ヘルスケア施設によるこれらの技術の使用は、これらの知見に後押しされています。

市場セグメンテーション

SPYシステムが最大セグメントと予測

心臓疾患の有病率が高まっていることから、手術成績を向上させるためにFGSを採用したSPYシステムが市場を席巻しています。SPYシステムと同様に、FGSシステムも手術中に特定の生物学的ターゲットとリアルタイムの組織灌流モニタリングを活用します。SPYシステムにより、外科医は最小限の困難で手術を行い、患者の転帰を改善することができます。したがって、これらのシステムは世界市場で大きなシェアを占めています。

地域別展望

蛍光誘導手術システムの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

臨床研究拠点としてのアジア太平洋諸国

  • アジア太平洋地域は、臨床研究とFGSの共同研究の中心地として、技術開発と臨床試験を実施するために学術機関と医療提供者が集まっています。
  • 蛍光ガイド下手技の償還に関する規制と政策は、地域によって特定のアプリケーションやヘルスケアプロバイダーによって異なります。

北米が主要市場シェアを占める

がんや心血管疾患を含む慢性疾患の有病率の高さ、高度な外科治療に対する意識の高さと需要の高さが、この地域の市場シェアに大きく貢献しています。さらに、同地域の高度なヘルスケアインフラと、外科手術に関する有利な医療償還政策が、同地域の市場成長を牽引しています。

世界の蛍光誘導手術システム市場に参入している主要企業には、浜松ホトニクス株式会社、オリンパス株式会社、Stryker Corp.、Medtronic PLC、Getinge ABなどがあります。市場競争力を維持するため、各社は提携、合併、買収などの戦略を適用し、事業拡大や製品開拓にますます力を注いでいます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主要業界動向
    • 市場推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Hamamatsu Photonics K.K.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Olympus Corp.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Stryker Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 蛍光誘導手術システムの世界市場：タイプ別
    • SPYシステム
    • PDEシステム
    • VS3イリジウムシステム
  • 蛍光誘導手術システムの世界市場：手術別
    • 開腹手術
    • 腹腔鏡/内視鏡
  • 蛍光誘導手術システムの世界市場：用途別
    • がん手術
    • 心臓血管外科
    • その他（消化器外科）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 企業プロファイル

  • 3M Company
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corp.
  • CONMED Corp.
  • Curadel LLC
  • Erbe Elektromedizin Gmbh
  • Getinge AB
  • Irillic Pvt. Ltd.
  • Johnson & Johnson Service, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • OnLume Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corp.
図表

LIST OF TABLES

  • 1. Global Fluorescence Guided Surgery System Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 2. Global Fluorescence Guided Surgery Spy System Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 3. Global Fluorescence Guided Surgery Pde System Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 4. Global Fluorescence Guided Surgery Vs3 Iridium System Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 5. Global Fluorescence Guided Surgery System Market Research And Analysis By Surgery, 2023-2031 ($ Million)
  • 6. Global Fluorescence Guided Surgery System For Open Surgery Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 7. Global Fluorescence Guided Surgery System For Laparoscopy/Endoscopy Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 8. Global Fluorescence Guided Surgery System Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 9. Global Fluorescence Guided Surgery System For Cancer Surgeries Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 10. Global Fluorescence Guided Surgery System For Cardiovascular Surgeries Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 11. Global Fluorescence Guided Surgery System For Other Applications Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 12. Global Fluorescence Guided Surgery System Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 13. North American Fluorescence Guided Surgery System Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 14. North American Fluorescence Guided Surgery System Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 15. North American Fluorescence Guided Surgery System Market Research And Analysis By Surgery, 2023-2031 ($ Million)
  • 16. North American Fluorescence Guided Surgery System Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 17. European Fluorescence Guided Surgery System Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 18. European Fluorescence Guided Surgery System Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 19. European Fluorescence Guided Surgery System Market Research And Analysis By Surgery, 2023-2031 ($ Million)
  • 20. European Fluorescence Guided Surgery System Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 21. Asia-Pacific Fluorescence Guided Surgery System Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 22. Asia-Pacific Fluorescence Guided Surgery System Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 23. Asia-Pacific Fluorescence Guided Surgery System Market Research And Analysis By Surgery, 2023-2031 ($ Million)
  • 24. Asia-Pacific Fluorescence Guided Surgery System Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 25. Rest Of The World Fluorescence Guided Surgery System Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 26. Rest Of The World Fluorescence Guided Surgery System Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 27. Rest Of The World Fluorescence Guided Surgery System Market Research And Analysis By Surgery, 2023-2031 ($ Million)
  • 28. Rest Of The World Fluorescence Guided Surgery System Market Research And Analysis By Application, 2023-2031 ($ Million)

LIST OF FIGURES

  • 1. Global Fluorescence Guided Surgery System Market Share By Type, 2023 Vs 2031 (%)
  • 2. Global Fluorescence Guided Surgery Spy System Market Share By Region, 2023 Vs 2031 (%)
  • 3. Global Fluorescence Guided Surgery Pde System Market Share By Region, 2023 Vs 2031 (%)
  • 4. Global Fluorescence Guided Surgery Vs3 Iridium System Market Share By Region, 2023 Vs 2031 (%)
  • 5. Global Fluorescence Guided Surgery System Market Share By Surgery, 2023 Vs 2031 (%)
  • 6. Global Fluorescence Guided Surgery System For Open Surgery Market Share By Region, 2023 Vs 2031 (%)
  • 7. Global Fluorescence Guided Surgery System For Laparoscopy/Endoscopy Market Share By Region, 2023 Vs 2031 (%)
  • 8. Global Fluorescence Guided Surgery System Market Share By Application, 2023 Vs 2031 (%)
  • 9. Global Fluorescence Guided Surgery System For Cancer Surgeries Market Share By Region, 2023 Vs 2031 (%)
  • 10. Global Fluorescence Guided Surgery System For Cardiovascular Surgeries Market Share By Region, 2023 Vs 2031 (%)
  • 11. Global Fluorescence Guided Surgery System For Other Applications Market Share By Region, 2023 Vs 2031 (%)
  • 12. Global Fluorescence Guided Surgery System Market Share By Region, 2023 Vs 2031 (%)
  • 13. US Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 14. Canada Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 15. UK Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 16. France Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 17. Germany Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 18. Italy Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 19. Spain Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 20. Rest Of Europe Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 21. India Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 22. China Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 23. Japan Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 24. South Korea Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 25. Rest Of Asia-Pacific Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 26. Latin America Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
  • 27. Middle East And Africa Fluorescence Guided Surgery System Market Size, 2023-2031 ($ Million)
目次
Product Code: OMR2028619

Fluorescence Guided Surgery System Market Size, Share & Trends Analysis Report by Type (SPY System, PDE System, and VS3 Iridium Systems), by Surgery (Open Surgery, and Laparoscopy/Endoscopy), and by Application (Cancer Surgeries, Cardiovascular Surgeries, and Others) Forecast Period (2024-2031)

Fluorescence-guided surgery system market is anticipated to grow at a CAGR of 15.7% during the forecast period (2024-2031). Fluorescence-guided surgery (FGS) is an optical imaging technique that uses invisible light to create a real-time image of the surgical area during a procedure. This helps surgeons identify and remove or preserve anatomical features like tumors, cancer cells, and nerves with greater precision and accuracy. FGS can also reduce the risk of damaging healthy tissue, which can shorten the operation and decrease the need for repeat surgeries.

Market Dynamics

A growing number of surgeries

The number of surgical procedures, healthcare spending, and regulatory approvals are all expected to increase, which will drive growth in the global FGS system market. Improved fluorescent probes that are extremely selective to malignant cells or target tissues are the result of research and development. During operations, these probes help doctors see the surgical site more clearly. Clinical evidence demonstrates that FGS improves patient outcomes, which motivates medical facilities to implement it during surgeries.

A rising number of research and development

Research and development activities result in the creation of ever-more-advanced fluorescent probes that are extremely selective to malignant cells or other target tissues. With the use of these probes, doctors can see the surgical site more clearly while performing their procedures. An expanding clinical data collection shows that FGS has improved patient outcomes. The use of these technologies by healthcare facilities is encouraged by these findings.

Market Segmentation

  • Based on type, the market is sub-segmented into SPY system, PDE system, and VS3 iridium system.
  • Based on surgery, the market is bifurcated into open surgery and laparoscopy/endoscopy.
  • Based on application, the market is segmented into cancer surgeries, cardiovascular surgeries, and others (gastrointestinal).

SPY System is Projected to Emerge as the Largest Segment

The growing prevalence of cardiac problems has led to a dominant market for the SPY system, which employs FGS to enhance surgical outcomes. Similar to the SPY system, FGS systems leverage particular biological targets and real-time tissue perfusion monitoring during surgery. With the SPY system, surgeons can perform procedures with minimal difficulties and improve patient outcomes. Hence, these systems hold a major share in the global market.

Regional Outlook

The global fluorescence-guided surgery system market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to serve as a clinical research center

  • The Asia-Pacific region serves as a center for clinical research and FGS collaboration, bringing together academic institutions and medical providers to conduct technology development and clinical trials.
  • Policies and regulations regarding reimbursement for fluorescence-guided procedures differ based on the particular application and healthcare provider across the region.

North America Holds Major Market Share

The high prevalence of chronic diseases including cancer and cardiovascular disease, as well as the high level of awareness and demand for sophisticated surgical treatments across the region, are the key contributors to the regional market share. Moreover, the advanced healthcare infrastructure of the region along with favorable medical reimbursement policies regarding surgical procedures are likely to drive the regional market growth.

The major companies serving the global fluorescence-guided surgery system market include Hamamatsu Photonics K.K., Olympus Corp., Stryker Corp., Medtronic PLC, and Getinge AB, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Industry Trends
    • 2.2.2. Market Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Hamamatsu Photonics K.K.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Olympus Corp.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Stryker Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Fluorescence Guided Surgery System Market by Type
    • 4.1.1. SPY System
    • 4.1.2. PDE System
    • 4.1.3. VS3 Iridium System
  • 4.2. Global Fluorescence Guided Surgery System Market by Surgery
    • 4.2.1. Open Surgery
    • 4.2.2. Laparoscopy/Endoscopy
  • 4.3. Global Fluorescence Guided Surgery System Market by Application
    • 4.3.1. Cancer Surgeries
    • 4.3.2. Cardiovascular Surgeries
    • 4.3.3. Others (Gastrointestinal Surgery)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. 3M Company
  • 6.2. B. Braun Melsungen AG
  • 6.3. Becton, Dickinson and Company (BD)
  • 6.4. Boston Scientific Corp.
  • 6.5. CONMED Corp.
  • 6.6. Curadel LLC
  • 6.7. Erbe Elektromedizin Gmbh
  • 6.8. Getinge AB
  • 6.9. Irillic Pvt. Ltd.
  • 6.10. Johnson & Johnson Service, Inc.
  • 6.11. Karl Storz SE & Co. KG
  • 6.12. Medtronic PLC
  • 6.13. OnLume Inc.
  • 6.14. PerkinElmer, Inc.
  • 6.15. Shimadzu Corp.